Press & Media
Roche Diabetes Care is pleased to be able to keep the diabetes community and interested media representatives up to date on our activities. A selection of press releases and publications are available below, we welcome further enquiries.
New stories
Roche Diabetes Care named finalist for ‘Most Promising Agile Transformation’ in Pharma Awards Europe 2020
Roche Diabetes Care announced today that it has been selected as a finalist in the ‘Most Promising Agile Transformation’ category in the Pharma Awards Europe 2020.
Roche Diabetes Care awarded silver in the Patient Partnership
Roche Diabetes Care has been awarded a Silver standard in the Patient Partnership Index in recognition of its support of type 1 diabetes charity JDRF (the Juvenile Diabetes Research Foundation).
Roche Diabetes Care joins forces with Boots to offer free access to mySugr Pro
Roche Diabetes Care today announced that it is delighted to have the support of pharmacy-led, health and beauty retailer, Boots, in offering its customers free access to the mySugr Pro diabetes management
Archive
Innovation in diabetes care in Wales - Webinar 1 July 2020
Innovation in diabetes care in Wales. Learning from lockdown and future implementation ideas.
Roche Diabetes Care to host webinar on best practice in diabetes management
The ongoing COVID-19 pandemic is an unprecedented challenge for the health system, necessitating new ways of working. As a company, we wish to offer our support by providing a year’s free access for all adults with diabetes to our diabetes management app, mySugr Pro, to help both patients and clinicians.
Roche Diabetes Care reassures that it will continue production of the Accu-Chek Aviva strip
The ongoing COVID-19 pandemic is an unprecedented challenge for the health system, necessitating new ways of working. As a company, we wish to offer our support by providing a year’s free access for all adults with diabetes to our diabetes management app, mySugr Pro, to help both patients and clinicians.
Free access to mySugr Pro diabetes management app for all adults with diabetes in the UK & Ireland at time of crisis
The ongoing COVID-19 pandemic is an unprecedented challenge for the health system, necessitating new ways of working. As a company, we wish to offer our support by providing a year’s free access for all adults with diabetes to our diabetes management app, mySugr Pro, to help both patients and clinicians.
Roche receives CE Mark for its Accu-Chek SugarView app
Roche today announced that it has obtained the CE Mark for its Accu-Chek SugarView app. This paves the way for the launch of the innovative diabetes management solution in the UK, across Europe and further countries around the world requiring the CE Mark.
Roche Diabetes Care committed to supporting people with diabetes in UK & Ireland
Diabetes needs to be addressed with an integrated, collaborative and personalised approach in order to cover all the different angles of this complex condition and meet the individual goals of each person with diabetes or at risk of developing the disease.
Roche renews its commitment to the primary healthcare Phelophepa trains, marking the 25th anniversary
Roche today announced its renewed support of the Phelophepa primary healthcare trains in South Africa as the main external sponsor to mark this milestone 25th anniversary.
Two hundred with type 1 diabetes benefit from Accu-Chek Solo managed access programme
Since the launch of the Accu-Chek Solo micropump, 200 people with type 1 diabetes in the UK are now using the device as part of a ‘Managed Access Programme’ benefiting from the latest in insulin delivery system technology.
Roche Diabetes Care promotes healthy lifestyle programme.
Roche Diabetes Care has partnered with OurPath since October 2017 to promote OurPath's healthy lifestyle programme throughout the UK and Ireland.
Roche Diabetes Care announce a 25% price drop for Accu-Chek Performa Nano test strips.
Today, Roche Diabetes Care announced that the price of Accu-Chek Performa Nano blood glucose test strips will be reduced from £9.95 to £7.50 on the NHS Drug Tarriff.
New Roche study uses real-world data to predict diabetes related chronic kidney disease.
Roche today announced promising results from a new study which supports the use of real-world data, including electronic medical record data, to predict the risk of chronic kidney disease (CKD) in individuals with diabetes.
Roche acquires mySugr to form a leading open platform for digital diabetes management.
Roche and mySugr announced today that the two partners have signed an agreement under which Roche acquired all shares of mySugr GBMH,